-
1
-
-
57749115652
-
Noroviruses a comprehensive review
-
January
-
Patel M.M., Hall A.J., Vinje J., Parashar U.D. Noroviruses a comprehensive review. J Clin Virol 2009, 44(January (1)):1-8.
-
(2009)
J Clin Virol
, vol.44
, Issue.1
, pp. 1-8
-
-
Patel, M.M.1
Hall, A.J.2
Vinje, J.3
Parashar, U.D.4
-
2
-
-
48749116831
-
Systematic literature review of role of noroviruses in sporadic gastroenteritis
-
August
-
Patel M.M., Widdowson M.A., Glass R.I., Akazawa K., Vinje J., Parashar U.D. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008, 14(August (8)):1224-1231.
-
(2008)
Emerg Infect Dis
, vol.14
, Issue.8
, pp. 1224-1231
-
-
Patel, M.M.1
Widdowson, M.A.2
Glass, R.I.3
Akazawa, K.4
Vinje, J.5
Parashar, U.D.6
-
3
-
-
70350553836
-
Norovirus gastroenteritis
-
October
-
Glass R.I., Parashar U.D., Estes M.K. Norovirus gastroenteritis. N Engl J Med 2009, 361(October (18)):1776-1785.
-
(2009)
N Engl J Med
, vol.361
, Issue.18
, pp. 1776-1785
-
-
Glass, R.I.1
Parashar, U.D.2
Estes, M.K.3
-
4
-
-
78649863790
-
An intranasally delivered Tlr7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles
-
December
-
Velasquez L.S., Hjelm B.E., Arntzen C.J., Herbst-Kralovetz M.M. An intranasally delivered Tlr7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clin Vaccine Immunol 2010, 17(December (12)):1850-1858.
-
(2010)
Clin Vaccine Immunol
, vol.17
, Issue.12
, pp. 1850-1858
-
-
Velasquez, L.S.1
Hjelm, B.E.2
Arntzen, C.J.3
Herbst-Kralovetz, M.M.4
-
5
-
-
0034802009
-
Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses
-
October
-
Guerrero R.A., Ball J.M., Krater S.S., Pacheco S.E., Clements J.D., Estes M.K. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol 2001, 75(October (20)):9713-9722.
-
(2001)
J Virol
, vol.75
, Issue.20
, pp. 9713-9722
-
-
Guerrero, R.A.1
Ball, J.M.2
Krater, S.S.3
Pacheco, S.E.4
Clements, J.D.5
Estes, M.K.6
-
6
-
-
0029891823
-
Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice
-
May
-
Mason H.S., Ball J.M., Shi J.J., Jiang X., Estes M.K., Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci U S A 1996, 93(May (11)):5335-5340.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, Issue.11
, pp. 5335-5340
-
-
Mason, H.S.1
Ball, J.M.2
Shi, J.J.3
Jiang, X.4
Estes, M.K.5
Arntzen, C.J.6
-
7
-
-
0031906229
-
Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice
-
February
-
Ball J.M., Hardy M.E., Atmar R.L., Conner M.E., Estes M.K. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol 1998, 72(February (2)):1345-1353.
-
(1998)
J Virol
, vol.72
, Issue.2
, pp. 1345-1353
-
-
Ball, J.M.1
Hardy, M.E.2
Atmar, R.L.3
Conner, M.E.4
Estes, M.K.5
-
8
-
-
0034120699
-
Norwalk virus vaccines: challenges and progress
-
May
-
Estes M.K., Ball J.M., Guerrero R.A., Opekun A.R., Gilger M.A., Pacheco S.S., et al. Norwalk virus vaccines: challenges and progress. J Infect Dis 2000, 81(May (Suppl 2)):S367-S373.
-
(2000)
J Infect Dis
, vol.81
, Issue.SUPPL 2
-
-
Estes, M.K.1
Ball, J.M.2
Guerrero, R.A.3
Opekun, A.R.4
Gilger, M.A.5
Pacheco, S.S.6
-
10
-
-
0033029541
-
Recombinant Norwalk virus-like particles given orally to volunteers: phase I study
-
July
-
Ball J.M., Graham D.Y., Opekun A.R., Gilger M.A., Guerrero R.A., Estes M.K. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 1999, 117(July (1)):40-48.
-
(1999)
Gastroenterology
, vol.117
, Issue.1
, pp. 40-48
-
-
Ball, J.M.1
Graham, D.Y.2
Opekun, A.R.3
Gilger, M.A.4
Guerrero, R.A.5
Estes, M.K.6
-
11
-
-
0013651896
-
Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes
-
July
-
Tacket C.O., Mason H.S., Losonsky G., Estes M.K., Levine M.M., Arntzen C.J. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 2000, 182(July (1)):302-305.
-
(2000)
J Infect Dis
, vol.182
, Issue.1
, pp. 302-305
-
-
Tacket, C.O.1
Mason, H.S.2
Losonsky, G.3
Estes, M.K.4
Levine, M.M.5
Arntzen, C.J.6
-
12
-
-
78649587261
-
Adjuvanted intranasal norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues
-
December
-
El-Kamary S.S., Pasetti M.F., Mendelman P.M., Frey S.E., Bernstein D.I., Treanor J.J., et al. Adjuvanted intranasal norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010, 202(December (11)):1649-1658.
-
(2010)
J Infect Dis
, vol.202
, Issue.11
, pp. 1649-1658
-
-
El-Kamary, S.S.1
Pasetti, M.F.2
Mendelman, P.M.3
Frey, S.E.4
Bernstein, D.I.5
Treanor, J.J.6
-
13
-
-
0027240069
-
Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations
-
August
-
Green K.Y., Lew J.F., Jiang X., Kapikian A.Z., Estes M.K. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol 1993, 31(August (8)):2185-2191.
-
(1993)
J Clin Microbiol
, vol.31
, Issue.8
, pp. 2185-2191
-
-
Green, K.Y.1
Lew, J.F.2
Jiang, X.3
Kapikian, A.Z.4
Estes, M.K.5
-
14
-
-
77957005956
-
Serological correlate of protection against norovirus-induced gastroenteritis
-
October
-
Reeck A., Kavanagh O., Estes M.K., Opekun A.R., Gilger M.A., Graham D.Y., et al. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 2010, 202(October (8)):1212-1218.
-
(2010)
J Infect Dis
, vol.202
, Issue.8
, pp. 1212-1218
-
-
Reeck, A.1
Kavanagh, O.2
Estes, M.K.3
Opekun, A.R.4
Gilger, M.A.5
Graham, D.Y.6
-
15
-
-
0034102041
-
Vaccines for mucosal immunity to combat emerging infectious diseases
-
March-April
-
van Ginkel F.W., Nguyen H.H., McGhee J.R. Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg Infect Dis 2000, 6(March-April (2)):123-132.
-
(2000)
Emerg Infect Dis
, vol.6
, Issue.2
, pp. 123-132
-
-
van Ginkel, F.W.1
Nguyen, H.H.2
McGhee, J.R.3
-
16
-
-
17644371966
-
Mucosal immunity and vaccines
-
April
-
Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11(April (4 Suppl)):S45-53.
-
(2005)
Nat Med
, vol.11
, Issue.4 SUPPL
-
-
Holmgren, J.1
Czerkinsky, C.2
-
17
-
-
0038330428
-
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
-
April
-
Holmgren J., Harandi A.M., Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev Vaccines 2003, 2(April (2)):205-217.
-
(2003)
Expert Rev Vaccines
, vol.2
, Issue.2
, pp. 205-217
-
-
Holmgren, J.1
Harandi, A.M.2
Czerkinsky, C.3
-
18
-
-
68049124726
-
Mucosal vaccines: novel advances in technology and delivery
-
August
-
Yuki Y., Kiyono H. Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines 2009, 8(August (8)):1083-1097.
-
(2009)
Expert Rev Vaccines
, vol.8
, Issue.8
, pp. 1083-1097
-
-
Yuki, Y.1
Kiyono, H.2
-
19
-
-
67649298021
-
Delivery strategies to enhance mucosal vaccination
-
April
-
Chadwick S., Kriegel C., Amiji M. Delivery strategies to enhance mucosal vaccination. Expert Opin Biol Ther 2009, 9(April (4)):427-440.
-
(2009)
Expert Opin Biol Ther
, vol.9
, Issue.4
, pp. 427-440
-
-
Chadwick, S.1
Kriegel, C.2
Amiji, M.3
-
20
-
-
47349113115
-
M cell-targeted delivery of vaccines and therapeutics
-
June
-
Kuolee R., Chen W. M cell-targeted delivery of vaccines and therapeutics. Expert Opin Drug Deliv 2008, 5(June (6)):693-702.
-
(2008)
Expert Opin Drug Deliv
, vol.5
, Issue.6
, pp. 693-702
-
-
Kuolee, R.1
Chen, W.2
-
21
-
-
77955882730
-
Mucosal delivery of human papillomavirus pseudovirus-encapsidated plas- 765 mids improves the potency of DNA vaccination
-
Graham B.S., Kines R.C., Corbett K.S., Nicewonger J., Johnson T.R., Chen M., et al. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plas- 765 mids improves the potency of DNA vaccination. Mucosal Immunol 2010, 3(5):475-486.
-
(2010)
Mucosal Immunol
, vol.3
, Issue.5
, pp. 475-486
-
-
Graham, B.S.1
Kines, R.C.2
Corbett, K.S.3
Nicewonger, J.4
Johnson, T.R.5
Chen, M.6
-
22
-
-
77955288601
-
Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B using a piglet model
-
Inskeep T.K., Stahl C., Odle J., Oakes J., Hudson L., Bost K.L., et al. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B using a piglet model. Clin Vaccine Immunol. 2010, 17(8):1163-1169.
-
(2010)
Clin Vaccine Immunol.
, vol.17
, Issue.8
, pp. 1163-1169
-
-
Inskeep, T.K.1
Stahl, C.2
Odle, J.3
Oakes, J.4
Hudson, L.5
Bost, K.L.6
-
23
-
-
62249122455
-
Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles
-
April
-
Fraillery D., Zosso N., Nardelli-Haefliger D. Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles. Vaccine 2009, 27(April (17)):2326-2334.
-
(2009)
Vaccine
, vol.27
, Issue.17
, pp. 2326-2334
-
-
Fraillery, D.1
Zosso, N.2
Nardelli-Haefliger, D.3
-
24
-
-
77954758686
-
Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx
-
July
-
Noda K., Kodama S., Umemoto S., Abe N., Hirano T., Suzuki M. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx. Vaccine. 2010, 28(July (31)):5068-5074.
-
(2010)
Vaccine.
, vol.28
, Issue.31
, pp. 5068-5074
-
-
Noda, K.1
Kodama, S.2
Umemoto, S.3
Abe, N.4
Hirano, T.5
Suzuki, M.6
-
25
-
-
77957327721
-
The mucosal immune response to plant-derived vaccines
-
Hefferon K.L. The mucosal immune response to plant-derived vaccines. Pharm Res 2010, 27(10):2040-2042.
-
(2010)
Pharm Res
, vol.27
, Issue.10
, pp. 2040-2042
-
-
Hefferon, K.L.1
-
26
-
-
77953121507
-
Simian recombinant adenovirus delivered by the mucosal route modulates gamma-delta T cells from murine genital tract
-
June
-
Lanza S.R., Menin A., Ertl H.C., Bafica A., Pinto A.R. Simian recombinant adenovirus delivered by the mucosal route modulates gamma-delta T cells from murine genital tract. Vaccine 2010, 28(June (29)):4600-4608.
-
(2010)
Vaccine
, vol.28
, Issue.29
, pp. 4600-4608
-
-
Lanza, S.R.1
Menin, A.2
Ertl, H.C.3
Bafica, A.4
Pinto, A.R.5
-
27
-
-
8144226081
-
A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats
-
December
-
Huang J., Garmise R.J., Crowder T.M., Mar K., Hwang C.R., Hickey A.J., et al. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine 2004, 23(December (6)):794-801.
-
(2004)
Vaccine
, vol.23
, Issue.6
, pp. 794-801
-
-
Huang, J.1
Garmise, R.J.2
Crowder, T.M.3
Mar, K.4
Hwang, C.R.5
Hickey, A.J.6
-
28
-
-
35448931929
-
Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination
-
Garmise R.J., Staats H.F., Hickey A.J. Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. AAPS PharmSciTech 2007, 8(4):E81.
-
(2007)
AAPS PharmSciTech
, vol.8
, Issue.4
-
-
Garmise, R.J.1
Staats, H.F.2
Hickey, A.J.3
-
29
-
-
3542998669
-
Nasal route and drug delivery systems
-
June
-
Turker S., Onur E., Ozer Y. Nasal route and drug delivery systems. Pharm World Sci 2004, 26(June (3)):137-142.
-
(2004)
Pharm World Sci
, vol.26
, Issue.3
, pp. 137-142
-
-
Turker, S.1
Onur, E.2
Ozer, Y.3
-
30
-
-
77249166118
-
The application of mucoadhesive polymers in nasal drug delivery
-
March
-
Jiang L., Gao L., Wang X., Tang L., Ma J. The application of mucoadhesive polymers in nasal drug delivery. Drug Dev Ind Pharm 2010, 36(March (3)):323-336.
-
(2010)
Drug Dev Ind Pharm
, vol.36
, Issue.3
, pp. 323-336
-
-
Jiang, L.1
Gao, L.2
Wang, X.3
Tang, L.4
Ma, J.5
-
31
-
-
0023243066
-
The common mucosal immune system and current strategies for induction of immune responses in external secretions
-
July
-
Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987, 7(July (4)):265-276.
-
(1987)
J Clin Immunol
, vol.7
, Issue.4
, pp. 265-276
-
-
Mestecky, J.1
-
32
-
-
67149120680
-
Dry powder nasal vaccines as an alternative to needle-based delivery
-
Hickey A.J., Garmise R.J. Dry powder nasal vaccines as an alternative to needle-based delivery. Crit Rev Ther Drug Carrier Syst 2009, 26(1):1-27.
-
(2009)
Crit Rev Ther Drug Carrier Syst
, vol.26
, Issue.1
, pp. 1-27
-
-
Hickey, A.J.1
Garmise, R.J.2
-
33
-
-
0032702094
-
Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
-
December
-
Treanor J.J., Kotloff K., Betts R.F., Belshe R., Newman F., Iacuzio D., et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 1999, 18(December (9-10)):899-906.
-
(1999)
Vaccine
, vol.18
, Issue.9-10
, pp. 899-906
-
-
Treanor, J.J.1
Kotloff, K.2
Betts, R.F.3
Belshe, R.4
Newman, F.5
Iacuzio, D.6
-
34
-
-
0033554086
-
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial
-
July
-
Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999, 282(July (2)):137-144.
-
(1999)
JAMA
, vol.282
, Issue.2
, pp. 137-144
-
-
Nichol, K.L.1
Mendelman, P.M.2
Mallon, K.P.3
Jackson, L.A.4
Gorse, G.J.5
Belshe, R.B.6
-
35
-
-
0032516267
-
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
-
May
-
Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998, 338(May (20)):1405-1412.
-
(1998)
N Engl J Med
, vol.338
, Issue.20
, pp. 1405-1412
-
-
Belshe, R.B.1
Mendelman, P.M.2
Treanor, J.3
King, J.4
Gruber, W.C.5
Piedra, P.6
-
36
-
-
0035940309
-
Nasal vaccines
-
September (1-3)
-
Davis S.S. Nasal vaccines. Adv Drug Deliv Rev 2001, 51(September (1-3)):21-42.
-
(2001)
Adv Drug Deliv Rev
, vol.51
, pp. 21-42
-
-
Davis, S.S.1
-
37
-
-
18744368156
-
Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation
-
June 11
-
Buonaguro L., Visciano M.L., Tornesello M.L., Tagliamonte M., Biryahwaho B., Buonaguro F.M. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation. J Virol 2005, 79(June 11):7059-7067.
-
(2005)
J Virol
, vol.79
, pp. 7059-7067
-
-
Buonaguro, L.1
Visciano, M.L.2
Tornesello, M.L.3
Tagliamonte, M.4
Biryahwaho, B.5
Buonaguro, F.M.6
-
38
-
-
0031668082
-
Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
-
October
-
Balmelli C., Roden R., Potts A., Schiller J., De Grandi P., Nardelli-Haefliger D. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol 1998, 72(October (10)):8220-8229.
-
(1998)
J Virol
, vol.72
, Issue.10
, pp. 8220-8229
-
-
Balmelli, C.1
Roden, R.2
Potts, A.3
Schiller, J.4
De Grandi, P.5
Nardelli-Haefliger, D.6
-
39
-
-
0032826809
-
Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice
-
November
-
Nardelli-Haefliger D., Roden R., Balmelli C., Potts A., Schiller J., De Grandi P. Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice. J Virol 1999, 73(November (11)):9609-9613.
-
(1999)
J Virol
, vol.73
, Issue.11
, pp. 9609-9613
-
-
Nardelli-Haefliger, D.1
Roden, R.2
Balmelli, C.3
Potts, A.4
Schiller, J.5
De Grandi, P.6
-
40
-
-
77950479638
-
The immunity of upper airways
-
January-March (1 Suppl)
-
Canessa C., Vierucci S., Azzari C., Vierucci A. The immunity of upper airways. Int J Immunopathol Pharmacol 2010, 23(January-March (1 Suppl)):8-12.
-
(2010)
Int J Immunopathol Pharmacol
, vol.23
, pp. 8-12
-
-
Canessa, C.1
Vierucci, S.2
Azzari, C.3
Vierucci, A.4
-
41
-
-
77954081810
-
Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers
-
June
-
Garg N.K., Mangal S., Khambete H., Sharma P.K., Tyagi R.K. Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers. Recent Pat Drug Deliv Formul 2010, 4(June (2)):114-128.
-
(2010)
Recent Pat Drug Deliv Formul
, vol.4
, Issue.2
, pp. 114-128
-
-
Garg, N.K.1
Mangal, S.2
Khambete, H.3
Sharma, P.K.4
Tyagi, R.K.5
-
42
-
-
55049117526
-
Mucoadhesive microspheres: a promising tool in drug delivery
-
October
-
Patil S.B., Sawant K.K. Mucoadhesive microspheres: a promising tool in drug delivery. Curr Drug Deliv 2008, 5(October (4)):312-318.
-
(2008)
Curr Drug Deliv
, vol.5
, Issue.4
, pp. 312-318
-
-
Patil, S.B.1
Sawant, K.K.2
-
43
-
-
77950666776
-
Evaluation of mucoadhesive PLGA microparticles for nasal immunization
-
June
-
Pawar D., Goyal A.K., Mangal S., Mishra N., Vaidya B., Tiwari S., et al. Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J 2010, 12(June (2)):130-137.
-
(2010)
AAPS J
, vol.12
, Issue.2
, pp. 130-137
-
-
Pawar, D.1
Goyal, A.K.2
Mangal, S.3
Mishra, N.4
Vaidya, B.5
Tiwari, S.6
-
44
-
-
77249166118
-
The application of mucoadhesive polymers in nasal drug delivery
-
March
-
Jiang L., Gao L., Wang X., Tang L., Ma J. The application of mucoadhesive polymers in nasal drug delivery. Drug Dev Ind Pharm 2010, 36(March (3)):323-336.
-
(2010)
Drug Dev Ind Pharm
, vol.36
, Issue.3
, pp. 323-336
-
-
Jiang, L.1
Gao, L.2
Wang, X.3
Tang, L.4
Ma, J.5
-
45
-
-
79960295788
-
Inventor in situ gel formation of pectin
-
USA Patent 6,777,000 B2;
-
Ni YaY, KM. Inventor in situ gel formation of pectin. USA Patent 6,777,000 B2; 2004.
-
(2004)
-
-
Ni YaY, K.M.1
-
46
-
-
14744283794
-
Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses
-
March
-
Huang Z., Elkin G., Maloney B.J., Beuhner N., Arntzen C.J., Thanavala Y., et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 2005, 23(March (15)):1851-1858.
-
(2005)
Vaccine
, vol.23
, Issue.15
, pp. 1851-1858
-
-
Huang, Z.1
Elkin, G.2
Maloney, B.J.3
Beuhner, N.4
Arntzen, C.J.5
Thanavala, Y.6
-
47
-
-
40849140609
-
An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles
-
March
-
Santi L., Batchelor L., Huang Z., Hjelm B., Kilbourne J., Arntzen C.J., et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26(March (15)):1846-1854.
-
(2008)
Vaccine
, vol.26
, Issue.15
, pp. 1846-1854
-
-
Santi, L.1
Batchelor, L.2
Huang, Z.3
Hjelm, B.4
Kilbourne, J.5
Arntzen, C.J.6
-
48
-
-
0015384219
-
Quantitative composition of nasal secretions in normal subjects
-
August
-
Lorin M.I., Gaerlan P.F., Mandel I.D. Quantitative composition of nasal secretions in normal subjects. J Lab Clin Med 1972, 80(August (2)):275-281.
-
(1972)
J Lab Clin Med
, vol.80
, Issue.2
, pp. 275-281
-
-
Lorin, M.I.1
Gaerlan, P.F.2
Mandel, I.D.3
-
49
-
-
77952668173
-
A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation
-
June
-
Saluja V., Amorij J.P., Kapteyn J.C., de Boer A.H., Frijlink H.W., Hinrichs W.L. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. J Control Release 2010, 144(June (2)):127-133.
-
(2010)
J Control Release
, vol.144
, Issue.2
, pp. 127-133
-
-
Saluja, V.1
Amorij, J.P.2
Kapteyn, J.C.3
de Boer, A.H.4
Frijlink, H.W.5
Hinrichs, W.L.6
-
50
-
-
0019824013
-
Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis
-
September
-
Rutland J., Cole P.J. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax 1981, 36(September (9)):654-658.
-
(1981)
Thorax
, vol.36
, Issue.9
, pp. 654-658
-
-
Rutland, J.1
Cole, P.J.2
-
51
-
-
77956193139
-
Evaluation of ISCOM matrices clearance from rabbit nasal cavity by gamma scintigraphy
-
October (1-2)
-
Pandey R.S., Babbar A.K., Kaul A., Mishra A.K., Dixit V.K. Evaluation of ISCOM matrices clearance from rabbit nasal cavity by gamma scintigraphy. Int J Pharm 2010, 398(October (1-2)):231-236.
-
(2010)
Int J Pharm
, vol.398
, pp. 231-236
-
-
Pandey, R.S.1
Babbar, A.K.2
Kaul, A.3
Mishra, A.K.4
Dixit, V.K.5
-
52
-
-
79960314952
-
Inventor delivery of physiological agents with in-situ gels comprising anionic polysaccharides
-
USA Patent 7,494,669.
-
Ni YaY, KM. Inventor delivery of physiological agents with in-situ gels comprising anionic polysaccharides. USA Patent 7,494,669; 2009.
-
(2009)
-
-
Ni YaY, K.M.1
-
53
-
-
9244265493
-
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
-
January
-
Alpar H.O., Somavarapu S., Atuah K.N., Bramwell V.W. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev 2005, 57(January (3)):411-430.
-
(2005)
Adv Drug Deliv Rev
, vol.57
, Issue.3
, pp. 411-430
-
-
Alpar, H.O.1
Somavarapu, S.2
Atuah, K.N.3
Bramwell, V.W.4
-
54
-
-
0035869132
-
Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment
-
March
-
Bernstein D.I., Harrison C.J., Tomai M.A., Miller R.L. Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. J Infect Dis 2001, 183(March (6)):844-849.
-
(2001)
J Infect Dis
, vol.183
, Issue.6
, pp. 844-849
-
-
Bernstein, D.I.1
Harrison, C.J.2
Tomai, M.A.3
Miller, R.L.4
-
55
-
-
0028835820
-
Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs
-
January
-
Bernstein D.I., Harrison C.J., Tepe E.R., Shahwan A., Miller R.L. Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs. Vaccine 1995, 13(January (1)):72-76.
-
(1995)
Vaccine
, vol.13
, Issue.1
, pp. 72-76
-
-
Bernstein, D.I.1
Harrison, C.J.2
Tepe, E.R.3
Shahwan, A.4
Miller, R.L.5
-
56
-
-
33646126484
-
An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits
-
May
-
Wimer-Mackin S., Hinchcliffe M., Petrie C.R., Warwood S.J., Tino W.T., Williams M.S., et al. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Vaccine 2006, 24(May (18)):3953-3963.
-
(2006)
Vaccine
, vol.24
, Issue.18
, pp. 3953-3963
-
-
Wimer-Mackin, S.1
Hinchcliffe, M.2
Petrie, C.R.3
Warwood, S.J.4
Tino, W.T.5
Williams, M.S.6
-
57
-
-
77949415982
-
Preparation and in vivo study of dry powder microspheres for nasal immunization
-
April
-
Tafaghodi M., Rastegar S. Preparation and in vivo study of dry powder microspheres for nasal immunization. J Drug Target 2010, 18(April (3)):235-242.
-
(2010)
J Drug Target
, vol.18
, Issue.3
, pp. 235-242
-
-
Tafaghodi, M.1
Rastegar, S.2
-
58
-
-
67349128324
-
Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
-
May
-
Baldwin S.L., Bertholet S., Kahn M., Zharkikh I., Ireton G.C., Vedvick T.S., et al. Intradermal immunization improves protective efficacy of a novel TB vaccine candidate. Vaccine 2009, 27(May (23)):3063-3071.
-
(2009)
Vaccine
, vol.27
, Issue.23
, pp. 3063-3071
-
-
Baldwin, S.L.1
Bertholet, S.2
Kahn, M.3
Zharkikh, I.4
Ireton, G.C.5
Vedvick, T.S.6
-
59
-
-
77953483935
-
Assessing the immunopotency of toll-like receptor agonists in an in vitro tissue-engineered immunological model
-
July
-
Ma Y., Poisson L., Sanchez-Schmitz G., Pawar S., Qu C., Randolph G.J., et al. Assessing the immunopotency of toll-like receptor agonists in an in vitro tissue-engineered immunological model. Immunology 2010, 130(July (3)):374-387.
-
(2010)
Immunology
, vol.130
, Issue.3
, pp. 374-387
-
-
Ma, Y.1
Poisson, L.2
Sanchez-Schmitz, G.3
Pawar, S.4
Qu, C.5
Randolph, G.J.6
|